Viking Therapeutics

YTD

ALL

Trade Viking Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About VKTX

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A.

CEO

Brian Lian

CEOBrian Lian

Employees

Employees36

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2012

Founded2012

Employees

Employees36

VKTX Key Statistics

Market cap

2.69B

Market cap2.69B

Price-Earnings ratio

-23.73

Price-Earnings ratio-23.73

Dividend yield

—

Dividend yield—

Average volume

5.55M

Average volume5.55M

High today

$24.12

High today$24.12

Low today

$21.23

Low today$21.23

Open price

$22.04

Open price$22.04

Volume

5.04M

Volume5.04M

52 Week high

$81.86

52 Week high$81.86

52 Week low

$18.92

52 Week low$18.92

VKTX News

Simply Wall St 10h

Viking Therapeutics (NasdaqCM:VKTX) Completes Enrollment For Phase 2 Trial Of VK2735

saw its stock rise by 11% over the last week, coinciding with significant developments in its clinical trials. The company's completion of subject enrollment fo...

Benzinga 5d

What's Going On With Viking Therapeutics, Structure Therapeutics Stock On Monday?

Viking Therapeutics, Inc. VKTX, Eli Lilly And Co LLY and Novo Nordisk A/S NVO stocks are trading higher on Monday. Pfizer Inc. PFE announced on Monday that it...

Analyst ratings

89%

of 18 ratings

Buy

88.9%

Hold

11.1%

Sell